
Soligenix SNGX
$ 0.33
4.06%
Annual report 2025
added 03-31-2026
Soligenix EV - Enterprise Value 2011-2026 | SNGX
Annual EV - Enterprise Value Soligenix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.13 M | -1.01 M | 3.64 M | 8.93 M | -8.13 M | 40.1 M | 48.6 M | 7.09 M | 9.06 M | 2.94 M | 25.4 M | 25.3 M | 39.7 M | 16.2 M | 4.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 48.6 M | -8.13 M | 14.9 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
4.15 M | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
MannKind Corporation
MNKD
|
1.76 B | $ 3.56 | 24.48 % | $ 1.09 B | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Bio-Techne Corporation
TECH
|
8.83 B | $ 47.41 | -16.36 % | $ 7.47 B | ||
|
United Therapeutics Corporation
UTHR
|
22.8 B | $ 596.76 | 4.29 % | $ 26.4 B | ||
|
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-4.92 M | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
-4.91 B | - | - | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | ||
|
INmune Bio
INMB
|
12.3 M | $ 1.52 | -1.3 % | $ 37.6 M | ||
|
Exelixis
EXEL
|
11.9 B | $ 48.7 | 9.64 % | $ 13.2 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
3.33 B | $ 21.48 | -3.89 % | $ 3.56 B | ||
|
Fortress Biotech
FBIO
|
122 M | - | - | $ 71.1 M | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
1.16 B | $ 3.15 | 1.19 % | $ 655 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | - | - | $ 5.51 M | ||
|
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
122 M | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 24.17 | 3.2 % | $ 3.08 B | ||
|
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
4.02 M | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
4.38 B | $ 55.08 | 5.15 % | $ 4.95 B | ||
|
Avenue Therapeutics
ATXI
|
-1.76 M | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.7 | 3.66 % | $ 452 M | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
3.14 B | - | - | - |